خط مشی دسترسیدرباره ماپشتیبانی آنلاین
ثبت نامثبت نام
راهنماراهنما
فارسی
ورودورود
صفحه اصلیصفحه اصلی
جستجوی مدارک
تمام متن
منابع دیجیتالی
رکورد قبلیرکورد بعدی
Information of biblio record :BL
Language of Text,Soundtrack etc.:English
Record identifier:510
Title and statement of responsibility and:Ethical and scientific issues in studying the safety of approved drugs /\ Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies.
Publication:Washington, D.C. :: National Academies Press,, c2012.
Physical Description:xvi, 275 p. ::ill. ;;23 cm.
Internal Bibliographies/Indexes:Includes bibliographical references and index.
Contents Note:Incorporating benefit and risk assessment and benefit/risk management into food and drug administration decision-making -- Evidence and decision-making -- Selection and oversight of required postmarketing studies -- Synthesis.
International Standard Book Number (ISBN):9780309218139 (pbk. : alk. paper)
9780309218146 (PDF)
Topical Name Used as Subject:Drugs-- Testing-- Moral and ethical aspects-- United States.
Topical Name Used as Subject:Clinical trials-- Moral and ethical aspects-- United States.
Topical Name Used as Subject:Drug approval-- United States.
Topical Name Used as Subject:Drug Evaluation-- ethics-- United States.
Topical Name Used as Subject:Clinical Trials as Topic-- ethics-- United States.
Topical Name Used as Subject:Drug Approval-- United States.
Topical Name Used as Subject:Product Surveillance, Postmarketing-- methods-- United States.
Added entry:Institute of Medicine (U.S.)., Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs.
LCC:‭RM301.27‬‭.E75 2012‬
Other Class Numbers:‭QV 771‬